Wellness Check: Exercise
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
Tag: weight loss
Adjustable intragastric balloons are an effective and well-tolerated weight loss intervention
1. A significantly greater reduction in total body weight was seen in the adjustable intragastric balloon group compared to the ...
Structured aerobic exercise may produce less weight loss than expected
1. In this study, significant weight loss occurred in the group performing aerobic exercise that expended 20 kcal/kg/week but was ...
Wellness Check: Exercise
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
Social media interventions may improve physical activity and mental wellness
1. In this meta-analysis, the impact of interactive social media interventions aimed at increasing physical activity was evaluated. 2. Improvements ...
#VisualAbstract: Health wearable devices effectively promote bodyweight in overweight/obese individuals
Use of accelerometer/pedometer-only and commercial health wearable-only were the most effective at reducing body weight in comparison with the other ...
Once weekly tirzepatide is superior to daily insulin degludec for treatment of uncontrolled type 2 diabetes
1. Patients receiving tirzepatide (5, 10, or 15 mg) reported significantly greater reductions in HbA1c compared to daily insulin degludec ...
#VisualAbstract: Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
#VisualAbstract: Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients on ...
